All studies
CompletedPhase IIObservational

Wrist Worn Trackers for monitoring activity in brain tumour patients

People with brain tumours often experience tiredness, muscle weakness, and balance problems caused by the tumour or treatments like radiotherapy and chemotherapy. Currently, doctors assess a patient's general fitness using a scoring scale developed over 50 years ago, which can sometimes be subjective and vary from person to person. This study tests whether a lightweight, wrist-worn tracker—similar to a digital watch—can provide a more objective measure of day-to-day physical activity. Researchers hope that tracking daily movement will show how well patients tolerate treatment, measure their overall well-being, and potentially provide an early warning sign if a tumour begins to grow again. Participants wear the device during their normal treatment and follow-up care for at least six months. Healthy caregivers can also take part to provide comparison data. Joining the study will not alter your standard NHS cancer treatment.

At a glance

Status
Completed
Phase
Phase II
Sponsor
Imperial College NHS Healthcare Trust
Enrolment target
70
Start
02 Jul 2018
Estimated completion
01 Jul 2022

What is this study about?

Living with a brain tumour can cause significant tiredness, muscle weakness, and balance issues. These problems can be triggered by the tumour itself or by treatments such as surgery, radiotherapy, and chemotherapy. When doctors decide which treatments are safe and suitable, they rely on a fitness score called 'performance status'. However, because this score is based on quick clinical impressions during clinic visits, it can vary between different doctors and may not show the full picture of how someone manages at home.

Modern wearable devices, similar to sports watches or fitness bands, offer a practical way to track movement patterns without disrupting daily life. In this study, called Brain Wear, researchers are using a small wrist sensor to continuously measure physical activity during the day and night while patients go about their everyday routines.

The main aim of the trial is to see if wearing the device is comfortable and practical for people living with brain tumours. The research team also wants to find out if changes in activity levels can show how well a patient is coping with their treatment, track their quality of life, or provide an early sign of a tumour returning. In the future, this technology could help doctors tailor treatments more closely to each person's needs.

Key takeaways

  • Tests whether a wrist-worn sensor can reliably monitor recovery and daily activity in people with brain tumours.
  • Open to adults aged 18 to 90 starting treatment for primary or secondary brain tumours, as well as healthy carers.
  • Involves wearing a lightweight, watch-like sensor day and night for at least six months.
  • Does not replace, delay, or change your planned cancer treatments.
  • Completely voluntary with no known physical risks or experimental medications.

Who may be eligible?

This study is open to adults aged between 18 and 90 who have been diagnosed with a primary brain tumour (a tumour that started in the brain) or a secondary brain tumour (cancer that spread to the brain from elsewhere in the body). Participants should be fit enough to receive active cancer treatment, such as surgery, radiotherapy, or chemotherapy. If you have been treated for a tumour in the past, at least six months must have passed since your previous treatment ended. Healthy family caregivers can also take part to help researchers compare activity levels.

The study is not suitable for people receiving whole-brain radiotherapy, or those who are very unwell and receiving palliative (comfort-focused) care alone. It also excludes people who have completed brain tumour treatment within the last six months.

To take part, you must be comfortable understanding information in English and agree to wear the wristband and upload your activity data. You do not need to own a smartphone to be eligible.

Could this study suit you?

Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.

  1. You are aged between 18 and 90 years old.
  2. You have a primary or secondary brain tumour and are preparing for active treatment (surgery, radiotherapy, or chemotherapy).
  3. It has been at least six months since you finished any previous brain tumour treatments.
  4. You are not having whole-brain radiotherapy.
  5. You are willing to wear a wrist tracker day and night and share the recorded data.
Answer every question to see your result.

What does participation involve?

If you take part, you will be given an Axivity AX3 wristband, which looks and feels like a standard wristwatch. You will be asked to wear it continuously on your wrist, both day and night, for at least six months while undergoing your planned cancer treatment and attending routine follow-up appointments. The tracker is water-resistant for daily use, but you will need to take it off when taking a bath or swimming.

This is an observational study, meaning it does not involve any experimental medications and will not change your normal hospital care. You will continue to see your usual healthcare team for all your planned cancer treatments. The research team will explain how the device collects data and how this information is returned or uploaded for the study. You are free to stop wearing the tracker or leave the study at any point.

Potential risks and benefits

There are no known physical risks to wearing the wrist tracker, which meets all UK safety standards for medical research. The tracker will not provide you with live step counts or personal fitness feedback during the study, so taking part will not directly improve your health. However, the information you provide could help doctors improve care and monitoring for future patients with brain tumours. Taking part is entirely voluntary, and you have the right to withdraw at any time without giving a reason and without it affecting your NHS care.

Locations (1)

  • Charing Cross Hospital
    Approximate
    London, England

Common questions

Do I need a smartphone or home computer to join?

No, you do not need to own a smartphone to take part. The study team will provide the equipment and explain how your movement data is collected.

Can I take the wrist tracker off if it feels uncomfortable?

Yes. You should wear it for as long as you feel comfortable, and you must take it off when having a bath or swimming. You can pause or stop taking part whenever you wish.

Will taking part change my normal cancer treatment?

No. Your cancer care, including surgery, chemotherapy, or radiotherapy, will carry on exactly as planned by your medical team.

Does the tracker display my daily steps or heart rate?

No. The device simply records raw movement data for researchers to study later, so it does not give live fitness feedback on a screen.

Can my main caregiver take part as well?

Yes. Healthy family caregivers can join as comparison volunteers, helping doctors compare patient activity against healthy daily routines.

How to find out more

Matthew Williams

Always speak to your GP or specialist before deciding to take part in a study.

Discussion

Community discussion

Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.